Genmab — Januar 2016
-
Siger han mere end 4000 patienter i non-MM studier der vil blive annonceret i år ?
-
JP Morgan dækker ikke Genmab pt. vel ?
-
Nej JPM dækker ikke Genmab
-
Det kan de komme til efter Jans salgstale i dag

-
dara+pom er 7 gange bedre end pom alene
siger Jan -
Hvis JPM begynder dækning, åbner det op for nye investorer
-
Gilead er mega tilfredse med Duo+Hexa siger jan :;)
-
Havde Jan ikke sagt at CD3+CD38 var en dårlig kombi
Sjovt de selv vælger CD3+CD20 som en fantastisk kombination 
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind